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Abstract
Class A and B carbapenemases in Enterobacteriaceae may be detected using carbapenemase inhibition tests with boronic acid derivatives
(BA) and dipicolinic acid (DPA)/EDTA, respectively. However, for OXA-48 (like) carbapenemases, no speciﬁc inhibitor is available. Because
OXA-48 confers high-level temocillin resistance, a disc diffusion assay using temocillin as well as BA and DPA inhibition tests was evaluated
for detection of class A, B and OXA-48 carbapenemases. The test collection included 128 well-characterized non-repeat Enterobacte-
riaceae isolates suspected of carbapenemase production; that is, with meropenem MICs ≥ 0.5 mg/L, including 99 carbapenemase producers
(36 KPC, one GES, 31 MBL, four KPC plus VIM, 25 OXA-48, two OXA-162), and 29 ESBL and/or AmpC-producing isolates. PCR and
sequencing of beta-lactamase genes was used as a reference test. Phenotypic carbapenemase detection was performed with discs (Rosco)
containing meropenem (10 lg), temocillin (30 lg), meropenem + phenyl boronic acid (PBA), meropenem + DPA, meropenem + BA + DPA,
and meropenem + cloxacillin (CL). Absence of synergy between meropenem and BA and/or DPA and a temocillin zone ≤10 mm was used
to identify OXA-48. The sensitivity for identiﬁcation of class A, B and OXA-48 carbapenemases was 95%, 90% and 100%, with 96–100%
speciﬁcity. In non-Proteus species, the sensitivity for class B carbapenemase detection was 97%. All isolates without PBA or DPA synergy and
a temocillin disc zone ≤10 mm were OXA-48 (like) positive. In conclusion, carbapenemase inhibition tests with PBA and DPA combined
with a temocillin disc provide a reliable phenotypic conﬁrmation method for class A, B and OXA-48 carbapenemases in Enterobacteriaceae.
Keywords: Boronic acid, carbapenemase, dipicolinic acid, Enterobacteriaceae, KPC, MBL, OXA-48, temocillin
Original Submission: 19 March 2013; Revised Submission: 27 June 2013; Accepted: 30 June 2013
Editor: R. Canton
Article published online: 4 July 2013
Clin Microbiol Infect 2014; 20: 345–349
10.1111/1469-0691.12322
Corresponding author: K. van Dijk, Department of Medical
Microbiology, Academic Medical Center, Room L1-246, Meibergdreef
9, 1105 AZ Amsterdam, the Netherlands
E-mail: K.vanDijk@amc.uva.nl
Introduction
The emergence and spread of carbapenemase-producing
Enterobacteriaceae (CPE) poses a considerable threat to
clinical patient care and public health. CPE are characterized by
their resistance to virtually all b-lactam antibiotics, and are
frequently co-resistant to ﬂuoroquinolones, aminoglycosides
and co-trimoxazole [1]. In Europe, the most prevalent
carbapenemases are KPC, NDM, VIM and OXA-48 [2,3].
Invasive infections with these strains are associated with high
rates of morbidity and mortality [4,5]. Accurate detection of
CPE is essential for infection control purposes, especially in an
outbreak setting and may have an impact on antibiotic therapy.
Although molecular identiﬁcation of carbapenemase genes
is the gold standard, phenotypic detection may be indicated
when molecular methods are not readily available. Several
studies have shown that sensitive and speciﬁc detection of
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class A and B carbapenemases may be performed using
carbapenemase inhibition disc diffusion tests (synergy tests)
with boronic acid derivatives (BA) and dipicolinic acid (DPA)/
EDTA, respectively [6–9]. However, for OXA-48 (like)
carbapenemases, no speciﬁc phenotypic identiﬁcation
method is available. Such a method is warranted because
OXA-48-producing Enterobacteriaceae are associated with
outbreaks, and the prevalence is rapidly rising throughout
Europe [3,10–12]. As it has been shown that OXA-48 confers
high-level resistance to temocillin [13,14], it has been hypoth-
esized that temocillin may be a useful indicator of OXA-48
production [15–17]. The aim of this study was to evaluate a
strategy for phenotypic detection and identiﬁcation of class A, B
and OXA-48 carbapenemases using temocillin disc diffusion
added to phenyl boronic acid (PBA) and DPA synergy tests.
Methods
The test collection included 128 well-characterized non-repeat
Enterobacteriaceae isolates suspected of carbapenemase pro-
duction (i.e. with meropenem MIC ≥ 0.5 mg/L). Of these
isolates, 72 were from a b-lactamase reference centre
(University Medical Centre Utrecht, the Netherlands) and
collected for detection of carbapenemase genes, 25 were from
Greece, six were from Germany, 20 were from New York,
and ﬁve were ATCC or NCTC reference strains (83
K. pneumoniae, 17 E. coli, 23 Enterobacter spp., three P. mirabilis,
two S. marcescens). The isolates produced KPC (n = 36), GES
(n = 1), MBL (VIM (n = 20), GIM (n = 6), NDM (n = 4), IMP
(n = 1)), a combination of KPC and MBL (n = 4), OXA-48
(n = 25), OXA-162 (n = 2), ESBL (n = 18), AmpC (n = 10) or
a combination of ESBL and AmpC (n = 1).
Genotypic detection of extended-spectrum b-lactamases,
carbapenemases, plasmid-mediated AmpC b-lactamases and
OXA b-lactamases was performed using PCR and sequencing,
as previously described [18]. Etests were used to determine
meropenem MICs (bioMerieux, Marcy l’Etoile, France).
Phenotypic carbapenemase conﬁrmation was performed
with discs (Rosco Diagnostica A/S, Taastrup, Denmark)
containing meropenem (10 lg), temocillin (30 lg), merope-
nem + phenyl boronic acid (PBA), meropenem + DPA,
meropenem + PBA + DPA, and meropenem + cloxacillin
(CL), using a 0.5 Mc Farland suspension of the isolates on
Mueller Hinton II agar plates (Becton Dickinson, New York,
NY, USA). Zone diameters were measured after overnight
incubation at 37°C. Table 1 shows the interpretation of the
PBA and DPA synergy tests and the temocillin disc diffusion.
The temocillin zone diameter was only interpreted if no
synergy was observed with DPA and/or PBA. Isolates without
synergy with the PBA or DPA test and a temocillin zone
diameter ≤10 mm (i.e. the absence of an inhibition zone
around the temocillin disc) were considered OXA carbape-
nemase positive. The modiﬁed Hodge test was performed
according to the CLSI guidelines [19].
The sensitivity and speciﬁcity of the phenotypic detection
methods were calculated using PCR and sequencing of
b-lactamases as the reference test. Data were analysed using
SPSS version 20.
Results
The results of the phenotypic carbapenemase detection tests
are shown in Tables 2 and 3. For identiﬁcation of class A
carbapenemases, the sensitivity of the PBA synergy test was
95% (35/37), with a speciﬁcity of 99% (90/91). One KPC-3-pro-
ducing K. pneumoniae and one K. pneumoniae producing GES-6
and SHV-5 were not detected, and one SHV-12-producing
Enterobacter cloacae was false-positive.
For identiﬁcation of class B carbapenemases, the sensitivity
of the DPA synergy test was 90% (28/31), with a speciﬁcity of
96% (93/97). Three MBL producers were not detected: one
IMP-28-producing K. pneumoniae showed an increase of only
3 mm in the DPA synergy test, and two P. mirabilis isolates
producing both CMY-16 and VIM-1 were negative because
swarming hampered interpretation. In non-Proteus species the
sensitivity was therefore 97% (28/29). Four isolates were
false-positive in the DPA synergy test: one CMY-2-positive
E. coli, one K. pneumoniae producing GES-6 and SHV-5, one
TABLE 1. Interpretation of phenyl boronic acid (PBA), cloxacillin and dipicolinic acid (DPA) synergy tests and temocillin disc
diffusion
Test Deﬁnition of positive test result
Class A
carbapenemase
Class B
carbapenemase
Class A plus B
carbapenemase
Class D
carbapenemase
AmpC +
porin loss
ESBL +
porin loss
PBA synergy test Meropenem  PBA ≥5 mm +    + 
Cloxacillin synergy test Meropenem  cloxacillin >5 mm     + 
DPA synergy test Meropenem  DPA ≥5 mm  +    
PBA+DPA synergy test Meropenem  PBA plus DPA ≥5 mm + + +   
Temocillin 30 lg disca Temocillin zone ≤10 mm    +  
aInterpreted only if PBA or DPA synergy is absent.
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E. cloacae producing CTX-M-9 and SHV-12, and one E. cloacae
producing SHV-12 (which was also false-positive in the PBA
detection test).
For identiﬁcation of Enterobacteriaceae producing KPC plus
MBL, the median increase in zone diameter in the double
synergy test with PBA and DPA was 9 mm (range 9–12 mm).
All four isolates were negative in the synergy tests using a
single inhibitor (DPA or PBA). These four isolates were all
K. pneumoniae producing KPC-2, VIM-1 and SHV-5.
For identiﬁcation of OXA-48 carbapenemases, the sensitivity
of the DPA and PBA synergy tests combined with temocillin
30 lg disc diffusion was 100%, with a speciﬁcity of 100%
(Table 3). Fig. 1 shows the temocillin disc zone diameters per
b-lactamase class. Absence of a temocillin disc zone (a disc zone
≤10 mm) was observed in all 27 OXA producers and in 20 of
the MBL producers. However, those 20 MBL producers all
showed synergy with DPA and were therefore interpreted as
MBL positive (Fig. 1). Thus, of all 57 isolates without synergy
with DPA and/or PBA (25 OXA-48, two OXA-162, three MBL,
one KPC and 26 ESBL and/or AmpC-producing isolates), only
the OXA producers had a temocillin zone ≤10 mm (Fig. 1). The
temocillin zone diameters of the three MBL-positive isolates
without synergy in the DPA test were 17 mm for both CMY-16
and VIM-1-producing P. mirabilis, and 21 mm for the
IMP-28-producing K. pneumoniae. The temocillin zone diameter
of the KPC-3-producing K. pneumoniae without synergy in the
PBA test was 16 mm and the temocillin zone diameter of the
K. pneumoniae producing GES-6 and SHV-5 without synergy in
the PBA test and synergy in the DPA test was 16 mm.
Using the modiﬁed Hodge test, four of the 99 carbape-
nemase-producing isolates were negative or dubious, and 95
were positive. Of the 29 carbapenemase-negative isolates, nine
isolates were dubious, three positive and 17 negative.
Considering the dubious results as positive, the sensitivity of
the modiﬁed Hodge test was 99% (98/99) and the speciﬁcity
59% (17/29).
Discussion
This is the ﬁrst study showing that addition of a temocillin
30 lg disc to the DPA and PBA synergy tests allows 100%
sensitive and speciﬁc detection of OXA-48 (like) carbapene-
mases in Enterobacteriaceae suspected of carbapenemase
production. All isolates without PBA or DPA synergy and a
temocillin disc zone ≤10 mm were OXA-48 (like) positive.
TABLE 3. Test characteristics of phenotypic conﬁrmation
tests for carbapenemase production in 99 carbapenem-
ase-positive and 29 carbapenemase-negative Enterobacteria-
ceae suspected of carbapenemase production (meropenem
MIC ≥ 0.5 mg/L)
Carbapenemase
detection test
Isolates per
carbapenemase
class Sensitivity Speciﬁcity
Phenyl boronic acid
(PBA) synergy test
Class A (n = 37) 95% (35/37) 99% (90/91)
Dipicolonic acid
(DPA) synergy test
Class B (n = 31) 90% (28/31)a 96% (93/97)
Synergy test with
PBA plus DPA
Class A plus B
(n = 4)
100% (4/4) Not tested
No synergy with
PBA or DPA and
temocillin zone ≤10 mm
Class D (n = 27) 100% (27/27) 100% (101/101)
Modiﬁed Hodge test All carbapenemases
(n = 99)
99% (98/99) 59% (17/29)
aThe sensitivity of the DPA synergy test in non-Proteus species was 97% (28/29).
TABLE 2. Results of dipicolinic acid (DPA), phenyl boronic acid (PBA) and cloxacillin (CL) synergy tests in 99 carbapenem-
ase-positive and 29 carbapenemase-negative Enterobacteriaceae suspected of carbapenemase production (meropenem
MIC ≥ 0.5 mg/L)
DPA synergy test PBA and CL synergy tests
b-Lactamase
class
Isolates per
b-lactamase
class (n)
Median (range)
zone increase
with DPA (mm)
Interpreted as Class
B carbapenemase
positivea (n)
Median (range)
zone increase with
PBA (mm)
Median (range)
zone increase
with CL (mm)
Interpreted as class
A carbapenemase
positivea (n)
Class A 37 1 (0–6) 1b 8 (3–12) 1 (0–5) 35c
Class B 31 11 (1–17) 28d 0 (2 to 3) 0 (1 to 5) 0
KPC + VIMg 4 3 (0–3) 0 0 (0–2) 0 (0–0) 0
OXA-48 (like) 27 0 (1 to 1) 0 0 (2 to 1) 0 (3 to 1) 0
ESBL 18 2 (1 to 7) 2e 0 (1 to 7) 1 (1 to 9) 1e
AmpC 10 2 (1 to 8) 1f 7 (0–12) 7 (0–11) 0
ESBL + AmpC 1 0 (0) 0 0 (0–0) 0 (0–0) 0
aSee Table 1.
bFalse-positive interpretation as class B carbapenemase positive: one K. pneumoniae producing GES-6 and SHV-5.
cOne KPC-3-producing K. pneumoniae and one K. pneumoniae producing GES-6 and SHV-5 not detected.
dTwo CMY-16 + VIM-1-producing P. mirabilis and one IMP-28-producing K. pneumoniae isolate not detected.
eFalse-positive interpretation as class B carbapenemase positive: one CTX-M-9 plus SHV-12-producing E. cloacae, one E. cloacae producing SHV-12 (which was also interpreted as
Class A positive).
fFalse-positive interpretation as MBL positive: one CMY-2-producing E. coli.
gAll isolates producing KPC + VIM were positive in the DPA + PBA double synergy test, data not shown.
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The sensitivity and speciﬁcity of the synergy tests using PBA
and DPA for phenotypic conﬁrmation of KPC and MBL
producers were in line with previous reports [6,8], although
difﬁcult interpretation of the disc diffusion synergy tests in
Proteus species because of swarming was not reported before.
In addition, the proposed strategy is unable to detect OXA-48
(like) carbapenemases in combination with an MBL. Although
not frequently encountered, these combinations have been
reported [20].
It should be noted that different zone diameter interpre-
tation criteria were used than those advised by the manufac-
turer in the latest package insert (KPC/MBL and OXA-48
Conﬁrm Kit (Rosco, 2/4/2013)), which resulted in lower
sensitivity for conﬁrmation of class A (76%) and class B (84%)
carbapenemases (data not shown).
Several other methods for detection of carbapenemases in
Enterobacteriaceae have been mentioned in the literature.
Compared with the modiﬁed Hodge test, the sensitivity of the
strategy proposed here was similar, but the speciﬁcity was
signiﬁcantly higher (59% vs. >96%, respectively, p <0.002). This
is a consequence of false-positive results of the modiﬁed
Hodge test in ESBL/AmpC-producing isolates with decreased
permeability, as documented in previous reports [21,22].
Compared with the carba NP test [23,24], a biochemical test
measuring imipenem hydrolysis of bacterial colonies within a
few hours using a pH indicator, the strategy proposed here is
relatively slow because an overnight incubation step is
required. Compared with MALDI-TOF [25,26] and spectro-
photometry-based methods [27], the assay proposed here
does not require investments, and the protocol and interpre-
tation are simple and straightforward.
In conclusion, the synergy tests with PBA and DPA
combined with a temocillin disc provide a practical, accurate
and cheap phenotypic conﬁrmation method for class A, B and
OXA-48 carbapenemase production in Enterobacteriaceae.
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